A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy

作者: Raymond W. Jurgens , Laurence J. Downey , William D. Abernethy , Neal R. Cutler , Julie Conrad

DOI: 10.1016/S0002-9378(11)91429-X

关键词:

摘要: Seventeen postmenopausal subjects were randomized into this comparative study of esterified estrogen 0.625 mg (Estratab), plus 1.25 methyltestosterone (Estratest H.S.), or conjugated (Premarin). Sixteen completed the in which plasma hormone concentrations estrone and estradiol assessed at various time points. There no significant differences among treatment groups.

参考文章(3)
Jelle T. Braaksma, William E. Brenner, John I. Fishburne, Linda Staurovsky, Intrauterine extra-amniotic administration of prostaglandin F2α for therapeutic abortion American Journal of Obstetrics and Gynecology. ,vol. 114, pp. 511- 515 ,(1972) , 10.1016/0002-9378(72)90212-8
C.Ann Mashchak, Rogerio A. Lobo, Ryoko Dozono-Takano, Peter Eggena, Robert M. Nakamura, Paul F. Brenner, Daniel R. Mishell, Comparison of pharmacodynamic properties of various estrogen formulations. American Journal of Obstetrics and Gynecology. ,vol. 144, pp. 511- 518 ,(1982) , 10.1016/0002-9378(82)90218-6
Morris Notelovitz, Estrogen replacement therapy: indications, contraindications, and agent selection American Journal of Obstetrics and Gynecology. ,vol. 161, pp. 1832- 1841 ,(1989) , 10.1016/S0002-9378(89)80003-1